Viewing Study NCT02326350


Ignite Creation Date: 2025-12-24 @ 4:59 PM
Ignite Modification Date: 2025-12-28 @ 4:30 AM
Study NCT ID: NCT02326350
Status: TERMINATED
Last Update Posted: 2019-03-13
First Post: 2014-12-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial
Sponsor: Belfast Health and Social Care Trust
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module